A joint study by University of Colorado Cancer Center and Memorial Sloan Kettering Cancer Center published in the Journal of Thoracic Oncology shows two distinct causes of HER2 activation in lung cancer: mutation of the gene and amplification of the gene. Show More Summary
A major transformation is beginning in cancer surgery that will enable patients to go home within a day of undergoing a significant operation. The new Josie Robertson Surgery Center (JRSC), opened by Memorial Sloan Kettering, exemplifies that transformation: a patient-focused facility that leverages technology and highly trained clinical teams to provide optimal care.
This is a guest post by Dr. Peter B. Bach, director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center in New York City. Last week, the drug giant Pfizer announced its plan to become an Irish drug company, moving its corporate headquarters abroad as part of a complex business maneuver […]
Memorial Sloan Kettering's new $300 million cancer center focuses on the well-being of the patient—even as they move you through the process as quickly as possible. Picture a hospital: Bright lights, buzzing machines, crowded waiting rooms, and frazzled nurses. Show More Summary
A robot is set to attend school for a 10-year-old girl with cancer and it will be in school for five weeks while she undergoes cancer treatment at Memorial Sloan Kettering Cancer Center in New York, a report from NBC Washington says....Show More Summary
A father is battling Memorial Sloan Kettering Cancer Center over the rights to developing a gene therapy that he hopes could cure his son’s blood disease.
A new JAMA Oncology study from Memorial Sloan Kettering Cancer Center finds that risk-adjusted Medicare claims data -- without information about the cancer stage of individual patients -- may be sufficient to calculate the long-term survival rates at hospitals providing cancer care in the United States.
Cornell University, in partnership with Memorial Sloan Kettering Cancer Center (MSKCC), is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.
Craig B. Thompson leads one of the country's most prestigious cancer hospitals, Memorial Sloan Kettering Cancer Center in New York. But noticeably absent from his online biographical sketch is his position as a director of one of the world’s biggest pharmaceutical companies, Merck, where over the past four years, he's received more than $1 million to serve on […]
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients' tumors rather than where their cancer originated.
Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.
Chambers Street Properties, a real estate investment trust, has sold a Montvale, N.J., property to a subsidiary of Memorial Sloan Kettering Cancer Center for $37 million. The 142,500-square-foot... To view the full story, click the title link.
Pereira & O’Dell New York unveiled the next phase of its “More science. Less fear.” campaign for Memorial Sloan Kettering Cancer Center, which launched last September, marking the agency’s first effort for the client since winning agency of record duties in February, 2014. Show More Summary
Giving people a new way to think and talk about cancer." That's the mission of three Internet films from New York's Memorial Sloan Kettering Cancer Center, according to chief communications officer Avice Meehan. "We started to frameShow More Summary
Statins have been shown to reduce complications from cardiovascular surgery. To determine whether statins might also help those undergoing major lung surgeries, a team at Memorial Sloan Kettering Cancer Center conducted a well-designed study that randomized patients to receive either a statin or placebo before and after surgery. Show More Summary
Roger Daltrey, the Rock And Roll Hall Of Fame crooner, was in New York this week. Yes, it was for The Who’s 50th Anniversary Tour but, as importantly, the rock icon was checking progress on a teen cancer center being developed at Memorial Sloan Kettering. In 2012, Daltrey and Elvis [...]
Memorial Sloan Kettering Cancer Center (MSK) introduced a new, consumer-friendly web presence for www.mskcc.org (Memorial Sloan Kettering Cancer Center) and www.sloankettering.edu (Louis V. Gerstner, Jr. Graduate School of Biomedical...Show More Summary
Researchers from Memorial Sloan Kettering Cancer Center (MSK) are pioneering a new groundbreaking clinical trial for children and young adults with relapsed or treatment-resistant acute lymphocytic leukemia (ALL) by using one of the most promising methods of cancer treatment today, chimeric antigen receptor (CAR) T cells.
CBS News medical contributor Dr. David Agus speaks with Dr. Jose Baselga, physician-in-chief and chief medical officer of Memorial Sloan Kettering Cancer Center, about the future of cancer treatment and genome mapping.
The effort --- a partnership with Memorial Sloan Kettering Cancer Center --- is said to detect the disease with 97 percent accuracy.